World - Biological Products - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Mar 1, 2024

World - Biological Products - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Biological Product Market

Biological product market: read recently published datasets powered by an Ai-driven BI tool. Data contain production, trade, companies, consumption, exports, market size, market prices, and imports. There is a split by region, including the U.K., China, Africa, the U.S., Latin America, EU, Russia, and the Middle East. Market insights and outlook to 2030 are also provided in the dashboards.


Get FREE access to the latest REPORT on the Biological Product Market. Make informed decisions with market maps on the DASHBOARD. Download datasets on the TABLE page.

Biological Product - World's Largest Markets

RatingCountry
1United States
2Germany
3Japan
4France
5Italy

In value terms, the United States, Germany and Japan appeared to be the countries with the highest levels of market value in 2020, together comprising 44% of the global market. France, Italy, India, Belgium, China, Spain, Canada, Russia, Mexico and Argentina lagged somewhat behind, together accounting for a further 33%.

France (+91.0% per year) saw the highest rates of growth with regard to market size, in terms of the main consuming countries over the period under review, while biological product market for the other global leaders experienced more modest paces of growth.

Biological Product Prices

Lowest Prices - FOB - Top Exporters

COUNTRY201820192020CAGR,
2018-2020
USD per ton
China45567578855871913.5%
Spain11313010827698301-6.8%
United States275085249800206197-13.4%
France258022207210216163-8.5%
United Kingdom254636251461245544-1.8%
South Korea521982539432413934-10.9%
Austria33699736055144732315.2%
Switzerland509113506622500026-0.9%
Ireland4232284713035020198.9%
Belgium733384709712665400-4.7%
Germany1063255936732990106-3.5%
Netherlands666469431358115031131.4%
Average404126408939393079-1.4%

Prices varied noticeably by the country of origin; the country with the highest price was the Netherlands ($1,150,311 per ton), while China ($58,719 per ton) was amongst the lowest.

From 2018 to 2020, the most notable rate of growth in terms of prices was attained by the Netherlands, while the other global leaders experienced more modest paces of growth.

Highest Prices - CIF - Top Importers

COUNTRY201820192020CAGR,
2018-2020
USD per ton
Germany692319521389111775727.1%
Switzerland87379682864410370488.9%
China53955281450995501133.0%
United States14570541107668877830-22.4%
Italy779491725543713724-4.3%
Belgium4254384785084543123.3%
Netherlands4364386429254406240.5%
Canada345481305691299514-6.9%
France472763405288273999-23.9%
Spain322558276920250180-11.9%
Austria195699177544170111-6.8%
Colombia4353061668491696.3%
Vietnam453454348144511-0.9%
Average496323467878479963-1.7%

There were significant differences in the average prices amongst the major importing countries. In 2020, the country with the highest price was Germany ($1,117,757 per ton), while Vietnam ($44,511 per ton) was amongst the lowest.

From 2018 to 2020, the most notable rate of growth in terms of prices was attained by China, while the other global leaders experienced more modest paces of growth.

Looking for Custom Market Insights?

Get the research you need to grow.
Schedule a free 30-minute talk with our expert.

Book Your Free Call
Aleksandr Romanenko
Aleksandr Romanenko

Biological Product - Top Importers

COUNTRY201820192020CAGR,
2018-2020
billion USD
United States37435319.0%
Germany353627-12.0%
Belgium19222411.2%
Switzerland17172111.2%
China8111223.3%

In value terms, the largest biological product importing markets worldwide were the United States ($52.5B), Germany ($27.5B) and Belgium ($23.6B), with a combined 42% share of global imports. These countries were followed by Switzerland, China, the Netherlands, Italy, France, Canada, Spain, Austria, Colombia and Vietnam, which together accounted for a further 30%.

Among the main importing countries, the Netherlands (+67.5% per year) recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Biological Product - Top Exporters

COUNTRY201820192020CAGR,
2018-2020
billion USD
Switzerland61707913.7%
Ireland27314224.8%
Germany565932-24.1%
Belgium13182845.1%
United States2326265.7%

In value terms, the largest biological product supplying countries worldwide were Switzerland ($79.4B), Ireland ($41.7B) and Germany ($32.3B), with a combined 54% share of global exports. These countries were followed by Belgium, the United States, the Netherlands, France, South Korea, Austria, the UK, China and Spain, which together accounted for a further 35%.

China (+135.2% per year) recorded the highest growth rate of the value of exports, among the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Biological Product - Market Forecast

Driven by increasing demand for biological product worldwide, the market is expected to continue an upward consumption trend over the next decade. Market performance is forecast to accelerate, expanding with an anticipated CAGR of for the period from 2020 to 2030, which is projected to bring the market volume to by the end of 2030.

Biological Product - Top Companies

Amgen Inc., CSL BEHRING (AUSTRALIA) PTY LTD, SEQIRUS PTY LTD, Csl Behring L.L.C., CSL Behring GmbH, China Animal Husbandry Group, Shanxi Beifangguokangbao Pesticide Co.,Ltd., COFCO Biochemical (AnHui) Co., Ltd., Celltrion, Inc., Hubei Anqi Biological Group Co., Ltd., SERUM INSTITUTE OF INDIA PRIVATE LIMITED, IRAN BLOOD TRANSFUSION ORGANIZATION COMPANY, China Animal Husbandry Industry Co., Ltd., Boehringer Ingelheim Vetmedica, Inc., Bpl Plasma, Inc., Albany Molecular Research, Inc., Sanofi Pasteur Inc., GSK Vaccines GmbH, EDWARDS LIFESCIENCES (SINGAPORE) PTE. LTD., SAMSUNG BIOLOGICS CO., LTD

Biological Product - Product Coverage

  • HS 300210 - Blood; human or animal, antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes
  • HS 300211 - Blood, human or animal, antisera, other blood fractions and immunological products; malaria diagnostic test kits
  • HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products; antisera and other blood fractions
  • HS 300213 - Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale
  • HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, mixed, put up in measured doses or in forms or packings for retail sale
  • HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale
  • HS 300219 - Blood, human or animal, antisera, other blood fractions and immunological products; n.e.c. in heading 3002.1
  • HS 300220 - Vaccines; for human medicine
  • HS 300230 - Vaccines; for veterinary medicine
  • HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the global biological product market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202120 -
  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine
  • Prodcom 21202160 - Vaccines for veterinary medicine
  • Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
  • Prodcom 21202320 - Blood-grouping reagents

Country coverage:

Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:

+ the largest producing countries

Data coverage:

  • Global market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Global production, split by region and country
  • Global trade (exports and imports)
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. CONSUMPTION BY COUNTRY
    3. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. GLOBAL PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
    2. PRODUCTION BY COUNTRY
  8. 8. GLOBAL IMPORTS

    The Largest Importers on The Market and How They Succeed

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. GLOBAL EXPORTS

    The Largest Exporters on The Market and How They Succeed

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. 11. COUNTRY PROFILES

    The Largest Markets And Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
    • United States
    • China
    • Japan
    • Germany
    • United Kingdom
    • France
    • Brazil
    • Italy
    • Russian Federation
    • India
    • Canada
    • Australia
    • Republic of Korea
    • Spain
    • Mexico
    • Indonesia
    • Netherlands
    • Turkey
    • Saudi Arabia
    • Switzerland
    • Sweden
    • Nigeria
    • Poland
    • Belgium
    • Argentina
    • Norway
    • Austria
    • Thailand
    • United Arab Emirates
    • Colombia
    • Denmark
    • South Africa
    • Malaysia
    • Israel
    • Singapore
    • Egypt
    • Philippines
    • Finland
    • Chile
    • Ireland
    • Pakistan
    • Greece
    • Portugal
    • Kazakhstan
    • Algeria
    • Czech Republic
    • Qatar
    • Peru
    • Romania
    • Vietnam
  12. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption, By Country, 2018–2023
    5. Production, In Physical Terms, By Country, 2012–2023
    6. Imports, In Physical Terms, By Country, 2012–2023
    7. Imports, In Value Terms, By Country, 2012–2023
    8. Import Prices, By Country Of Destination, 2012–2023
    9. Exports, In Physical Terms, By Country, 2012–2023
    10. Exports, In Value Terms, By Country, 2012–2023
    11. Export Prices, By Country Of Origin, 2012–2023
  13. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Consumption, By Country, 2023
    4. Market Volume Forecast to 2030
    5. Market Value Forecast to 2030
    6. Products: Market Size And Growth, By Type
    7. Products: Average Per Capita Consumption, By Type
    8. Products: Exports And Growth, By Type
    9. Products: Export Prices And Growth, By Type
    10. Production Volume And Growth
    11. Exports And Growth
    12. Export Prices And Growth
    13. Market Size And Growth
    14. Per Capita Consumption
    15. Imports And Growth
    16. Import Prices
    17. Production, In Physical Terms, 2012–2023
    18. Production, In Value Terms, 2012–2023
    19. Production, By Country, 2023
    20. Production, In Physical Terms, By Country, 2012–2023
    21. Imports, In Physical Terms, 2012–2023
    22. Imports, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, By Country, 2023
    24. Imports, In Physical Terms, By Country, 2012–2023
    25. Imports, In Value Terms, By Country, 2012–2023
    26. Import Prices, By Country, 2012–2023
    27. Exports, In Physical Terms, 2012–2023
    28. Exports, In Value Terms, 2012–2023
    29. Exports, In Physical Terms, By Country, 2023
    30. Exports, In Physical Terms, By Country, 2012–2023
    31. Exports, In Value Terms, By Country, 2012–2023
    32. Export Prices, 2012–2023
Store
Blog
Event
Best Import Markets for Biological Products
Nov 21, 2023
Eye 213

Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.

The Largest Import Markets for Antisera
Nov 27, 2023
Eye 241

Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.

Global Trade in Antisera and Other Blood Fractions Skyrockets to Record $182B
Dec 6, 2021
Eye 1099

Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland. 

Switzerland and Germany are Main Suppliers on the Global Antisera Market
Jun 26, 2018
Eye 1043

In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries. 

Which Country Imports the Most Antisera in the World?
May 28, 2018
Eye 1224

In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...

Which Country Exports the Most Antisera in the World?
May 28, 2018
Eye 1217

In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...

Antisera Market - Global Trade in Antisera and Other Blood Fractions Shows Robust Growth
Nov 3, 2016
Eye 3198

From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.

Switzerland Topped the World's Exports of Antisera and Other Blood Fractions, with $25.7B in 2014
Jul 16, 2015
Eye 477

Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G

Global Vaccine Trade Gains Momentum, Surpassing $42B This Year
Oct 21, 2021
Eye 574

Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.

Vaccine Market - Vaccine Exports From Belgium Seen Growing, Totaling $10,526M in 2014
Jul 8, 2015
Eye 1213

Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o

Free Data: Biological Products (except Diagnostic) - World